Literature DB >> 9416815

The role of quantitative electromyography in inclusion body myositis.

T H Brannagan1, A P Hays, D J Lange, W Trojaborg.   

Abstract

OBJECTIVE AND METHODS: Inclusion body myositis is said to have both myopathic and neurogenic features on electrophysiological tests. Twenty one studies from 20 patients with biopsy defined inclusion body myosis, 13 of whom had quantitative electromyography (qEMG), were reviewed to determine if this technique added diagnostic specificity (one patient had both needle EMG and a later study with qEMG before muscle biopsy).
RESULTS: Excessive numbers of polyphasic motor unit potentials (MUPs) (> 12% per muscle) were seen in 11 of the 13 patients. In 10 of 13 patients, mean MUP duration was abnormally reduced (26% to 48%). In three patients, mean MUP duration was abnormally reduced only after polyphasic MUPs were excluded. In all 13 patients, the simple MUP duration was reduced. Myopathy was unequivocally diagnosed in all 13 studies that included qEMG; of the remaining eight patients, the conclusions of the electrophysiological studies without qEMG was myopathy (one), neurogenic (four) or non-diagnostic (three).
CONCLUSIONS: There is no evidence of a neurogenic component in inclusion body myosis if qEMG is used. Quantitative EMG is often necessary to make an electrophysiological diagnosis of a myogenic disorder in patients with inclusion body myosis.

Entities:  

Mesh:

Year:  1997        PMID: 9416815      PMCID: PMC2169851          DOI: 10.1136/jnnp.63.6.776

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Action potential parameters in normal human muscle and their dependence on physical variables.

Authors:  F BUCHTHAL; C GULD; P ROSENFALCK
Journal:  Acta Physiol Scand       Date:  1954-11

2.  Electrophysiological spectrum of inclusion body myositis.

Authors:  J L Joy; S J Oh; A I Baysal
Journal:  Muscle Nerve       Date:  1990-10       Impact factor: 3.217

3.  Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy.

Authors:  S Carpenter; G Karpati; I Heller; A Eisen
Journal:  Neurology       Date:  1978-01       Impact factor: 9.910

Review 4.  Electromyography in the evaluation of muscle diseases.

Authors:  F Buchthal
Journal:  Neurol Clin       Date:  1985-08       Impact factor: 3.806

5.  The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders.

Authors:  F Buchthal; Z Kamieniecka
Journal:  Muscle Nerve       Date:  1982-04       Impact factor: 3.217

6.  Inclusion body myositis. Observations in 40 patients.

Authors:  B P Lotz; A G Engel; H Nishino; J C Stevens; W J Litchy
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

7.  Inclusion body myositis. A corticosteroid-resistant idiopathic inflammatory myopathy.

Authors:  M J Danon; M G Reyes; O H Perurena; J C Masdeu; J R Manaligod
Journal:  Arch Neurol       Date:  1982-12

8.  Long-duration polyphasic motor unit potentials in myopathies: a quantitative study with pathological correlation.

Authors:  A Uncini; D J Lange; R E Lovelace; M Solomon; A P Hays
Journal:  Muscle Nerve       Date:  1990-03       Impact factor: 3.217

9.  Quantitative EMG in inflammatory myopathy.

Authors:  P E Barkhaus; S D Nandedkar; D B Sanders
Journal:  Muscle Nerve       Date:  1990-03       Impact factor: 3.217

10.  Inclusion body myositis (IBM): myopathy or neuropathy?

Authors:  A Eisen; K Berry; G Gibson
Journal:  Neurology       Date:  1983-09       Impact factor: 9.910

View more
  2 in total

1.  An Android Application for Estimating Muscle Onset Latency using Surface EMG Signal.

Authors:  M Karimpour; H Parsaei; Z Rojhani-Shirazi; R Sharifian; F Yazdani
Journal:  J Biomed Phys Eng       Date:  2019-04-01

2.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.